MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
    1.
    发明申请
    MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS 审中-公开
    包含S1P蛋白质的标记物组合物,用于预测OSTEOPOROTIC FRACTURE和OSTEOPOSOSIS的风险

    公开(公告)号:US20130331282A1

    公开(公告)日:2013-12-12

    申请号:US13865688

    申请日:2013-04-18

    Abstract: Disclosed herein is a marker composition that includes sphingosine 1-phosphate (S1P) protein and that may be used to predict the risk of fracture or osteoporosis; a kit that includes an antibody that specifically binds to the S1P protein and that can be used to predict the risk of fracture or osteoporosis; and a method that can be used to obtain information that allows prediction of the risk of fracture or osteoporosis and includes measurements of S1P protein concentrations by measuring the binding of a S1P-specific antibody to S1P protein. The S1P protein disclosed herein is highly expressed in individuals with fracture, regardless of their bone mineral density. Accordingly, it may be useful as a biomarker of the risk of fracture or osteoporosis.

    Abstract translation: 本文公开了包含鞘氨醇1-磷酸(S1P)蛋白质并可用于预测骨折或骨质疏松症风险的标记物组合物; 包括特异性结合S1P蛋白并可用于预测骨折或骨质疏松症风险的抗体的试剂盒; 以及可用于获得允许预测骨折或骨质疏松症风险的信息的方法,并且包括通过测量S1P特异性抗体与S1P蛋白的结合来测量S1P蛋白浓度。 本文公开的S1P蛋白质在具有骨折的个体中高度表达,而不管其骨矿物质密度如何。 因此,作为骨折或骨质疏松症风险的生物标志物可能是有用的。

Patent Agency Ranking